Abstract Details
|
David S. Lynch, MBBS, PhD
PRESENTER |
Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lynch has received research support from Ionis. |
| Thomas J. Williams, MD (UPMC) | Dr. Williams has nothing to disclose. |
| Nevin A. John, MBBS (Monash Health) | Dr. John has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Henry Houlden | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Jeremy S. Chataway, MD | Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. |